Huperzine A is an acetylcholinesterase inhibitor and NMDA receptor antagonist. Huperzine A is extracted from Huperzia serrata. Huperzine A has been investigated as a possible treatment for diseases characterized by neurodegeneration – particularly Alzheimer's disease. As of 2013 although some research suggests it may be helpful, the evidence overall is not convincing enough for it to be recommended for use as a medicine, and little is known of its safety. Huperzine A is also marketed as a dietary supplement with claims made for its ability to improve memory and mental function.
Properties:
Appearance & Physical State: white to slight white crystaline powder
Density: 1.2 g/cm3
Boiling Point: 505ºC at 760 mmHg
Melting Point: 211-216ºC
Flash Point: 259.2ºC
Refractive Index: 1.626
AChR Inhibitors Related Products:
Donepezil Hcl; PNU-120596; Scopolamine hydrobromide; Rivastigmine Tartrate; Darifenacin hydrobromide; Vinblastine sulfate; Tolterodine tartrate; Amfebutamone hydrochloride; Solifenacin; Solifenacin succinate; Trospium chloride; Pyridostigmine bromide; Varenicline; Revefenacin; Imidafenacin